These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26344911)

  • 21. Design and synthesis of novel 2-(4-(2-(dimethylamino)ethyl)-4H-1,2,4-triazol-3-yl)pyridines as potential antitumor agents.
    Qin M; Zhai X; Xie H; Ma J; Lu K; Wang Y; Wang L; Gu Y; Gong P
    Eur J Med Chem; 2014 Jun; 81():47-58. PubMed ID: 24826815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YM-359445, an orally bioavailable vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, has highly potent antitumor activity against established tumors.
    Amino N; Ideyama Y; Yamano M; Kuromitsu S; Tajinda K; Samizu K; Hisamichi H; Matsuhisa A; Shirasuna K; Kudoh M; Shibasaki M
    Clin Cancer Res; 2006 Mar; 12(5):1630-8. PubMed ID: 16533791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Click ferrocenyl-erlotinib conjugates active against erlotinib-resistant non-small cell lung cancer cells in vitro.
    Biegański P; Godel M; Riganti C; Kawano DF; Kopecka J; Kowalski K
    Bioorg Chem; 2022 Feb; 119():105514. PubMed ID: 34864281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Series of N-aryltriazole and N-acridinyltriazole Hybrids as Potential Anticancer Agents.
    Rono CK; Darkwa J; Meyer D; Makhubela BCE
    Curr Org Synth; 2019; 16(6):900-912. PubMed ID: 31984911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of Novel Fluoro Phenyl Triazoles
    Aguilar J; Leyva E; Loredo-Carrillo SE; Cárdenas-Chaparro A; Martínez-Richa A; Hernández-López H; Araujo-Huitrado JG; Granados-López AJ; López-Hernández Y; López JA
    Curr Org Synth; 2024; 21(4):559-570. PubMed ID: 37078356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments.
    Elsebaie HA; Abdulla MH; Elsayed ZM; Shaldam MA; Tawfik HO; Morsy SN; Vaali Mohammed MA; Bin Traiki T; Elkaeed EB; Abdel-Aziz HA; Eldehna WM
    Bioorg Chem; 2024 Oct; 151():107626. PubMed ID: 39013242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
    Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
    Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2.
    Salerno S; Marini AM; Fornaciari G; Simorini F; La Motta C; Taliani S; Sartini S; Da Settimo F; García-Argáez AN; Gia O; Cosconati S; Novellino E; D'Ocon P; Fioravanti A; Orlandi P; Bocci G; Dalla Via L
    Eur J Med Chem; 2015 Oct; 103():29-43. PubMed ID: 26318056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introducing of acyclonucleoside analogues tethered 1,2,4-triazole as anticancer agents with dual epidermal growth factor receptor kinase and microtubule inhibitors.
    Aouad MR; Al-Mohammadi HM; Al-Blewi FF; Ihmaid S; Elbadawy HM; Althagfan SS; Rezki N
    Bioorg Chem; 2020 Jan; 94():103446. PubMed ID: 31791685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of theophylline containing acetylenes and theophylline containing 1,2,3-triazoles with variant nucleoside derivatives.
    Ruddarraju RR; Murugulla AC; Kotla R; Chandra Babu Tirumalasetty M; Wudayagiri R; Donthabakthuni S; Maroju R; Baburao K; Parasa LS
    Eur J Med Chem; 2016 Nov; 123():379-396. PubMed ID: 27487568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triazole-estradiol analogs: A potential cancer therapeutic targeting ovarian and colorectal cancer.
    Ostlund T; Alotaibi F; Kyeremateng J; Halaweish H; Kasten A; Iram S; Halaweish F
    Steroids; 2022 Jan; 177():108950. PubMed ID: 34933058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of novel chiral TBBt derivatives with hydroxyl moiety. Studies on inhibition of human protein kinase CK2α and cytotoxicity properties.
    Borowiecki P; Wawro AM; Wińska P; Wielechowska M; Bretner M
    Eur J Med Chem; 2014 Sep; 84():364-74. PubMed ID: 25036794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Click' synthesis of a triazole-based inhibitor of Met functions in cancer cells.
    Colombo F; Tintori C; Furlan A; Borrelli S; Christodoulou MS; Dono R; Maina F; Botta M; Amat M; Bosch J; Passarella D
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4693-6. PubMed ID: 22738633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking.
    Eldehna WM; Fares M; Ibrahim HS; Aly MH; Zada S; Ali MM; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA
    Eur J Med Chem; 2015 Jul; 100():89-97. PubMed ID: 26071861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A convergent synthesis of alkyne-azide cycloaddition derivatives of 4-α,β-2-propyne podophyllotoxin depicting potent cytotoxic activity.
    Zilla MK; Nayak D; Vishwakarma RA; Sharma PR; Goswami A; Ali A
    Eur J Med Chem; 2014 Apr; 77():47-55. PubMed ID: 24607588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel VEGFR-2 kinase inhibitors identified by the back-to-front approach.
    Sanphanya K; Wattanapitayakul SK; Phowichit S; Fokin VV; Vajragupta O
    Bioorg Med Chem Lett; 2013 May; 23(10):2962-7. PubMed ID: 23562241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of 1H-1,2,3-triazole linked aryl(arylamidomethyl) - dihydrofurocoumarin hybrids and analysis of their cytotoxicity.
    Lipeeva AV; Pokrovsky MA; Baev DS; Shakirov MM; Bagryanskaya IY; Tolstikova TG; Pokrovsky AG; Shults EE
    Eur J Med Chem; 2015 Jul; 100():119-28. PubMed ID: 26079088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Click chemistry inspired one-pot synthesis of 1,4-disubstituted 1,2,3-triazoles and their Src kinase inhibitory activity.
    Kumar D; Reddy VB; Kumar A; Mandal D; Tiwari R; Parang K
    Bioorg Med Chem Lett; 2011 Jan; 21(1):449-52. PubMed ID: 21084189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors.
    Suzuki T; Muto N; Bando M; Itoh Y; Masaki A; Ri M; Ota Y; Nakagawa H; Iida S; Shirahige K; Miyata N
    ChemMedChem; 2014 Mar; 9(3):657-64. PubMed ID: 24403121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semi-synthesis and biological evaluation of 1,2,3-triazole-based podophyllotoxin congeners as potent antitumor agents inducing apoptosis in HepG2 cells.
    Chen J; Ma L; Zhang R; Tang J; Lai H; Wang J; Wang G; Xu Q; Chen T; Peng F; Qiu J; Liang X; Cao D; Ran Y; Peng A; Wei Y; Chen L
    Arch Pharm (Weinheim); 2012 Dec; 345(12):945-56. PubMed ID: 22949330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.